Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)

T. Meniawy, G. Richardson, A. Townsend, J. Desai, Hui K. Gan, Michael Friedlander, L. Horvath, M. B. Jameson, S. Sandhu, Z. Wu, Z. Qin, K. Kang, B. Markman

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Number of pages1
JournalAnnals of Oncology
Volume28
Publication statusPublished - Sept 2017
Externally publishedYes
Event42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain
Duration: 8 Sept 201712 Sept 2017

Cite this